Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2012 Jan 01;72:e32557. doi: 10.1371/journal.pone.0032557.
Show Gene links
Show Anatomy links
γ-Aminobutyric acid transporter 2 mediates the hepatic uptake of guanidinoacetate, the creatine biosynthetic precursor, in rats.
Tachikawa M
,
Ikeda S
,
Fujinawa J
,
Hirose S
,
Akanuma S
,
Hosoya K
.
???displayArticle.abstract???
Guanidinoacetic acid (GAA) is the biosynthetic precursor of creatine which is involved in storage and transmission of phosphate-bound energy. Hepatocytes readily convert GAA to creatine, raising the possibility that the active uptake of GAA by hepatocytes is a regulatory factor. The purpose of this study is to investigate and identify the transporter responsible for GAA uptake by hepatocytes. The characteristics of [(14)C]GAA uptake by hepatocytes were elucidated using the in vivo liver uptake method, freshly isolated rat hepatocytes, an expression system of Xenopus laevis oocytes, gene knockdown, and an immunohistochemical technique. In vivo injection of [(14)C]GAA into the rat femoral vein and portal vein results in the rapid uptake of [(14)C]GAA by the liver. The uptake was markedly inhibited by γ-aminobutyric acid (GABA) and nipecotinic acid, an inhibitor of GABA transporters (GATs). The characteristics of Na(+)- and Cl(-)-dependent [(14)C]GAA uptake by freshly isolated rat hepatocytes were consistent with those of GAT2. The Km value of the GAA uptake (134 µM) was close to that of GAT2-mediated GAA transport (78.9 µM). GABA caused a marked inhibition with an IC(50) value of 8.81 µM. The [(14)C]GAA uptake exhibited a significant reduction corresponding to the reduction in GAT2 protein expression. GAT2 was localized on the sinusoidal membrane of the hepatocytes predominantly in the periportal region. This distribution pattern was consistent with that of the creatine biosynthetic enzyme, S-adenosylmethionine:guanidinoacetate N-methyltransferase. GAT2 makes a major contribution to the sinusoidal GAA uptake by periportal hepatocytes, thus regulating creatine biosynthesis in the liver.
???displayArticle.pubmedLink???
22384273
???displayArticle.pmcLink???PMC3288109 ???displayArticle.link???PLoS One
Figure 1. In vivo blood-to-liver transport of GAA.(A) [14C]GAA uptake by the liver after its intravenous administration. Each point represents the mean±SEM (n = 5–7). (B) Concentration-dependent uptake of GAA by rat liver after its injection into the portal vein. The extravascular extraction of [14C]GAA was plotted against the concentration of unlabeled GAA in the injection solution. Each point represents the mean±SEM (n = 3–4). (C) Simultaneous injection of unlabeled creatine had no effect on [14C]creatine uptake by the liver. Each column represents the mean±SEM (n = 5–6).
Figure 2. Characteristics of [14C]GAA uptake by freshly isolated rat hepatocytes.(A) Time-course of [14C]GAA (18 µM) uptake (open circle) and [14C]creatine (30 µM) uptake (closed circle) by hepatocytes. Inset graph shows no effect of unlabeled creatine (10 mM) on the [14C]creatine uptake at 2 min. Each point represents the mean±SEM (n = 3–4). (B) Concentration-dependence of GAA uptake by hepatocytes. The uptake was measured at the indicated concentration for 3 min. Each point represents the mean±SEM (n = 4). (C–E) Inhibitory effect of GABA (C), taurine (D), and creatine (E) on [14C]GAA uptake by freshly isolated rat hepatocytes. [14C]GAA (18 µM) uptake for 3 min at 37°C was measured in the presence and absence (control) of each compound at the designated concentrations. Each point represents the mean±SEM (n = 3–4). (F) Effect of treatment of shRNA, unrelated or targeted to GAT2, for 24 h on [14C]GAA (18 µM) uptake by primary cultures of rat hepatocytes at 37°C for 3 min. Immunoblotting (inset) with antibodies to GAT2 and Na+, K+-ATPase used as an internal standard shows the reduction of GAT2 protein expression in GAT2-silenced hepatocytes. Each column represents the mean±SEM (n = 4). *p<0.01, significantly different from the control.
Figure 3. Characteristics of GAA transport in Xenopus laevis oocytes expressing GAT2 (GAT2/oocytes).(A) Uptake of [14C]GAA (45 µM), and [14C]creatine (45 µM) by oocytes injected with water (Water; open column) and GAT2 cRNA (GAT2; closed column) for 1 h at 20°C. Each column represents the mean±SEM (n = 8–14). *p<0.01, significantly different from the control. (B) Time-courses of [14C]GAA uptake (45 µM) by oocytes injected with water (closed circle) and GAT2 cRNA (open circle) at 20°C. The [14C]GAA uptake was inhibited by unlabeled GAA (10 mM; open square). Each point represents the mean±SEM (n = 9–15). *p<0.01, significantly different from the control. (C) Concentration-dependence of [14C]GAA uptake by GAT2/ooccytes at 20°C. The uptake was measured at the indicated concentration for 1 h. Each point represents the mean±SEM (n = 5–15).
Figure 4. Expression and localization of GAT2 in rat liver.Red and green fluorescence is defined at the lower left corner of each panel. (A) Immunoblot of GAT2, oatp1a4, and MRP6 in rat liver and heart. Rat heart was used as negative control for oatp1a4 and MRP6 expression. The size of the marker proteins is indicated to the left. (B–C) Preferential distribution of GAT2 (B and C) and GAMT (C) in hepatocytes around the portal vein. (D–E) Distribution of GAT2 and oatp1a4 in the liver. E3 inset: Localization of GAT2 on the oatp1a4-positive sinusoidal membrane (arrowheads). (F) Plasma membrane localization of GAT2 in GAMT-positive hepatocytes. (G) Double immunofluorescence of GAT2 and MRP6, a marker of the lateral membrane of hepatocytes. Arrowheads indicate the bile canaliculus. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI, blue). In B–E, single (*) and double (**) asterisks indicate the portal spaces and the central vein, respectively. Scale bars: B–D, 100 µm; E–G, 10 µm.
Arrúe,
GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.
2010, Pubmed
Arrúe,
GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.
2010,
Pubmed
Berry,
High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.
1969,
Pubmed
Borden,
Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain.
1992,
Pubmed
Braissant,
Creatine deficiency syndromes and the importance of creatine synthesis in the brain.
2011,
Pubmed
Burger,
Different capacities for amino acid transport in periportal and perivenous hepatocytes isolated by digitonin/collagenase perfusion.
1989,
Pubmed
Fujita,
Hepatic uptake of gamma-butyrobetaine, a precursor of carnitine biosynthesis, in rats.
2009,
Pubmed
Groothuis,
Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport.
1982,
Pubmed
Harris,
The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis.
2006,
Pubmed
Liu,
beta-alanine and alpha-fluoro-beta-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2.
1999,
Pubmed
Madon,
Transport function and hepatocellular localization of mrp6 in rat liver.
2000,
Pubmed
Marescau,
Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals.
1992,
Pubmed
McGuire,
Localization of L-arginine-glycine amidinotransferase protein in rat tissues by immunofluorescence microscopy.
1986,
Pubmed
Nasrallah,
Creatine and creatine deficiency syndromes: biochemical and clinical aspects.
2010,
Pubmed
Noël,
gamma-butyrobetaine in tissues and serum of fed and starved rats determined by an enzymic radioisotopic procedure.
1984,
Pubmed
Ohtsuki,
The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain.
2002,
Pubmed
Pardridge,
Transport of protein-bound steroid hormones into liver in vivo.
1979,
Pubmed
Payne,
Structural characterization and tissue-specific expression of the mRNAs encoding isoenzymes from two rat mitochondrial creatine kinase genes.
1991,
Pubmed
Petzinger,
Uptake of bumetanide into isolated rat hepatocytes and primary liver cell cultures.
1989,
Pubmed
Reichel,
Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver.
1999,
Pubmed
,
Xenbase
Schmidt,
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency.
2004,
Pubmed
Sora,
The cloning and expression of a human creatine transporter.
1994,
Pubmed
Stoll,
Functional hepatocyte heterogeneity in glutamate, aspartate and alpha-ketoglutarate uptake: a histoautoradiographical study.
1991,
Pubmed
Stöckler,
Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man.
1996,
Pubmed
Stöckler,
Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.
1997,
Pubmed
Tachikawa,
Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
2008,
Pubmed
,
Xenbase
Tachikawa,
The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
2009,
Pubmed
,
Xenbase
Tachikawa,
Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis.
2004,
Pubmed
Trask,
Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs.
1990,
Pubmed
Warskulat,
Chronic liver disease is triggered by taurine transporter knockout in the mouse.
2006,
Pubmed
Wyss,
Creatine and creatinine metabolism.
2000,
Pubmed
Yamaoka,
A pharmacokinetic analysis program (multi) for microcomputer.
1981,
Pubmed
Zhang,
Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
1992,
Pubmed
da Silva,
Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo.
2009,
Pubmed
